本院「AXL與MERTK為標的之癌症免疫療法藥物BPR5K系列」公開徵求產學合作或技術移轉廠商 (2022/8/12)
本院「AXL與MERTK為標的之癌症免疫療法藥物BPR5K系列」公開徵求產學合作或技術移轉廠商 公告日期：11 …
本院「AXL與MERTK為標的之癌症免疫療法藥物BPR5K系列」公開徵求產學合作或技術移轉廠商 (2022/8/12) Read More »
Latest news-English
{:tw}Latest news of TTIC. Including Technology Transfer, industry-academia collaborations and so on. {:}
Technology Available for Industry-Academia Collaboration or Technology Licensing. “An Aurora kinase inhibitor for precision targeting of MYC-amplified cancers” (2022/01/03)
1. Title: NHRI technology, “An Aurora kinase inhibitor …
本院公開徵選「幹細胞外泌體(Exosomes from Stem Cells) 之疾病治療技術」專屬授權技術移轉廠商 NHRI technology, “Exosomes from Stem Cells for Treatment” available for technology licensing
一、 主旨： 本院公開徵選「幹細胞外泌體(Exosomes from Stem Cells) 之疾病治療技術」 …
本院「鴉片受體變構調節劑DBPR116」公開徵求產學合作或技術移轉廠商 (2021/1/28)
一、主旨：本院「鴉片受體變構調節劑DBPR116」計畫公開徵求產學合作或技術移轉廠商。 二、技術說明：DBPR …
NHRI technology, “Induction of Stem Cell-derived Exosomes for Disease Treatment” available for technology licensing (exclusive license), 2020/08/17
Subject NHRI technology, “Induction of Stem Cell-derive …
